Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Department of Pathology and Laboratory Medicine, The Ottawa Hospital, Ottawa, ON, Canada.
Endocr Pathol. 2023 Dec;34(4):471-483. doi: 10.1007/s12022-023-09787-9. Epub 2023 Oct 4.
Anaplastic thyroid carcinoma (ATC) demonstrates a wide variety of morphologies and is characteristically associated with a differentiated thyroid carcinoma component. Heterologous differentiation is a rare, potentially challenging phenomenon in ATC, mostly observed as osteosarcomatous or chondrosarcomatous differentiation. We now describe a novel 'glomangiosarcoma-like' differentiation, review our archival experience from two institutions (UPMC, CC), and perform a systematic review for the prevalence of heterologous elements in ATC. The patient is a 57-year-old female who presented with 4.5 cm left thyroid, and 3.4 cm neck masses. Histologically, the thyroid demonstrated a differentiated high grade papillary thyroid carcinoma, tall cell and hobnail/micropapillary subtypes transitioning into an anaplastic component with spindled to ovoid cells with hemangiopericytoma-like vasculature showing CD34 positivity, variable muscle marker expression and pericellular lace-like type IV collagen deposition. The neck mass consisted solely of the latter morphology. Targeted next-generation sequencing was performed on high grade DTC and adjacent ATC from the thyroid as well as ATC from the neck metastasis. All three components shared BRAF, TERT promoter, and PIK3CA mutations confirming a clonal origin. Archival (UPMC: n = 150, CC: n = 74) and literature review showed no prior examples. Systematic review and meta-analysis of prevalence showed a baseline pooled prevalence (generalized linear mixed model) of heterologous elements of any type to be 1.6% (95% confidence interval: 1.0-2.6%) for studies where this was specifically addressed. ATC with glomangiosarcoma-like heterologous differentiation is a rarity among an already rare morphologic category with unique diagnostic pitfalls.
间变性甲状腺癌(ATC)表现出多种形态,通常与分化型甲状腺癌成分相关。异源性分化是 ATC 中一种罕见的、具有潜在挑战性的现象,主要表现为骨肉瘤样或软骨肉瘤样分化。我们现在描述一种新的“glomangiosarcoma-like”分化,回顾我们在两个机构(UPMC、CC)的存档经验,并对 ATC 中异源性成分的患病率进行系统综述。患者为 57 岁女性,表现为左甲状腺 4.5cm 和 3.4cm 颈部肿块。组织学上,甲状腺显示出分化程度高的高级别乳头状甲状腺癌,高细胞和钉突/微乳头状亚型向具有梭形至卵圆形细胞的间变性成分转化,伴血管外皮细胞瘤样血管,CD34 阳性,可变的肌肉标志物表达和细胞周花边样 IV 型胶原沉积。颈部肿块仅由后者的形态组成。对甲状腺中的高级别 DTC 和相邻 ATC 以及颈部转移灶中的 ATC 进行了靶向下一代测序。所有三个成分均共享 BRAF、TERT 启动子和 PIK3CA 突变,证实了克隆起源。存档(UPMC:n=150,CC:n=74)和文献复习均未发现先前的例子。对患病率的系统综述和荟萃分析显示,在专门解决此问题的研究中,任何类型的异源性成分的基线汇总患病率(广义线性混合模型)为 1.6%(95%置信区间:1.0-2.6%)。具有glomangiosarcoma-like 异源性分化的 ATC 在已经罕见的形态类别中非常罕见,具有独特的诊断陷阱。